Delta Financial Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $40K | Sell |
23,150
-200
| -0.9% | -$346 | 0.01% | 257 |
|
|
2024
Q4 | $51K | Buy |
23,350
+1,600
| +7% | +$3.5K | 0.01% | 249 |
|
|
2024
Q3 | $36K | Sell |
21,750
-1,200
| -5% | -$1.99K | 0.01% | 137 |
|
|
2024
Q2 | $51K | Sell |
22,950
-300
| -1% | -$667 | 0.02% | 121 |
|
|
2024
Q1 | $62K | Hold |
23,250
| – | – | 0.02% | 233 |
|
|
2023
Q4 | $70K | Buy |
23,250
+100
| +0.4% | +$301 | 0.02% | 218 |
|
|
2023
Q3 | $23K | Hold |
23,150
| – | – | 0.01% | 206 |
|
|
2023
Q2 | $32K | Hold |
23,150
| – | – | 0.04% | 85 |
|
|
2023
Q1 | $37K | Sell |
23,150
-200
| -0.9% | -$320 | 0.01% | 180 |
|
|
2022
Q4 | $137K | Buy |
+23,350
| New | +$137K | 0.06% | 169 |
|